Recall: D-0553-2023

Class II - Potentially Harmful

Class IIClassification

2023-03-16Initiated

OngoingStatus

Northwind Pharmaceuticals LLCFirm

Product

Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-54), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.

Reason

CGMP Deviations

Distribution

Nationwide with the United States

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.